Evidence map›Paper›PMID 33385336›Full record

ArticleCell host & microbe2021

Murine model of colonization with fungal pathogen Candida auris to explore skin tropism, host risk factors and therapeutic strategies.

Xin Huang, Charlotte Hurabielle, Rebecca A Drummond, Nicolas Bouladoux, Jigar V Desai, Choon K Sim, Yasmine Belkaid, Michail S Lionakis, Julia A Segre

Open access · bronzeAbstract read
In one paragraph

Article in Cell host & microbe, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed, 2 pooled it
1.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 2 syntheses or guidelines pooled it, 130 citations in OpenAlex.

  1. Methods for skin load reduction of Candida auris: a systematic review.Antimicrobial resistance and infection control · 2026
    Pooled it
  2. Global characteristics and trends in research onFrontiers in microbiology · 2023
    Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. ManagingInfection prevention in practice · 2026
    Article
  9. Diabetes and Immunosuppression Drive Distinct Patterns ofbioRxiv : the preprint server for biology · 2026
    Article
  10. Article
  11. Article
  12. Risk Factors Associated With Progression to Clinical Candida auris Infection Among Adults With Previous Colonization-Florida, 2019-2023.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  13. mBio · 2026
    Article
  14. Article
  15. Journal of fungi (Basel, Switzerland) · 2026
    Review
  16. Microbiology and molecular biology reviews : MMBR · 2026
    Review
  17. Microbiology spectrum · 2026
    Article
  18. Review
  19. Article
  20. Review

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Xin HuangMicrobial Genomics Section, National Human Genome Research Institute, NIH, Bethesda, MD 20892, USA.
Charlotte HurabielleMetaorganism Immunity Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA.
Rebecca A DrummondFungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA.
Nicolas BouladouxMetaorganism Immunity Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA; NIAID Microbiome Program, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892, USA.
Jigar V DesaiFungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA.
Choon K SimMicrobial Genomics Section, National Human Genome Research Institute, NIH, Bethesda, MD 20892, USA.
Yasmine BelkaidMetaorganism Immunity Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA; NIAID Microbiome Program, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892, USA.
Michail S LionakisFungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA. Electronic address: lionakism@niaid.nih.gov.
Julia A SegreMicrobial Genomics Section, National Human Genome Research Institute, NIH, Bethesda, MD 20892, USA. Electronic address: jsegre@nhgri.nih.gov.
National Institute of Allergy and Infectious Diseases · USNational Human Genome Research Institute · US

Funding

Immunopathogenesis of Fungal InfectionsZIAAI001175 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI LIONAKIS, MICHAIL · 2012 to 2025
$23.9M
Role of the microbiota in immunityZIAAI001115 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI BELKAID, YASMINE · 2009 to 2025
$22.4M
NIAID Microbiome ProgramZICAI001233 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI MOUTSOPOULOS, NIKI · 2018 to 2025
$18.9M
Microbial genomics of hospital-associated pathogensZIAHG200382 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI SEGRE, JULIA ANGELA · 2012 to 2025
$9.1M
Role of Tissue-Specific Factors in the Control of ImmunityZIAAI001132 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI BELKAID, YASMINE · 2011 to 2025
$6.4M
Transcriptional Regulation of Epidermal DifferentiationZ01HG000180 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI SEGRE, JULIA ANGELA · 2001 to 2008
$2.4M
Intramural NIH HHS Z01 HG000180Intramural NIH HHS ZIA AI001175Intramural NIH HHS ZIA HG200382
6 · The paper itself

Abstract

Candida auris is an emerging multi-drug-resistant human fungal pathogen. C. auris skin colonization results in environmental shedding, which underlies hospital transmissions, and predisposes patients to subsequent infections. We developed a murine skin topical exposure model for C. auris to dissect risk factors for colonization and to test interventions that might protect patients. We demonstrate that C. auris establishes long-term residence within the skin tissue compartment, which would elude clinical surveillance. The four clades of C. auris, with geographically distinct origins, differ in their abilities to colonize murine skin, mirroring epidemiologic findings. The IL-17 receptor signaling and specific arms of immunity protect mice from long-term C. auris skin colonization. We further determine that commonly used chlorhexidine antiseptic serves as a protective and decolonizing agent against C. auris. This translational model facilitates an integrated approach to develop strategies to combat the unfolding global outbreaks of C. auris and other skin-associated microbial pathogens.

Indexed as

Viral TropismAnimalsAntifungal AgentsAnti-Infective Agents, LocalCandidaCandidiasisChlorhexidineDisease Models, AnimalInterleukin-17MiceMice, Inbred C57BLMice, KnockoutReceptors, Interleukin-17Risk FactorsSkinTh17 CellsAntifungal AgentsAnti-Infective Agents, LocalChlorhexidineIl17a protein, mouseIl17f protein, mouseInterleukin-17Receptors, Interleukin-17adaptive and innate immunityCandida aurisepidemiologyfungal pathogenskin colonizationtranslational mouse model

Identifiers

PMID33385336
PMCPMC7878403
OpenAlexW3114762667

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.